Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jia‐Yi Wu
Observed names:
J Wu,
Jia-Yi Wu,
Jiayi Wu,
Jia‐yi Wu
Institution:
Beijing University of Chinese Medicine
Observed institutions:
Beijing University of Chinese Medicine,
Zhejiang Cancer Hospital,
University of Chinese Academy of Sciences
ORCID:
0000-0001-8517-4648
Observed ORCID:
0000-0001-8517-4648
OpenAlex ID:
A5068613274
Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment
2024
·
Jiayi Wu
, Wei Wang
, et al.
·
Cancer
·
23
PDF
P01.01 PLAP as target for cancer immunotherapy – development and preclinical characterization of bispecific monoclonal antibody in colorectal cancer immunotherapy
2022
·
NS Alrishedan
, W Bodmer
, et al.
·
Journal for ImmunoTherapy of Cancer
·
4
PDF
Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple‐negative breast cancer
2024
·
Xia‐Bo Shen
, Jia‐Yi Wu
, et al.
·
Clinical Case Reports
·
2
PDF
Research Progress on Chemical Constituents and Pharmacological Effects of Amides From Natural Sources
2026
·
Xiao‐fei Yang
, Cheng‐yuan Su
, et al.
·
Chemistry & Biodiversity
·
1
PDF
[Application of activity-based protein profiling technology in TCM targets: a review].
2026
·
Xiao-Fei Yang
, Chang Xu
, et al.
·
PubMed
Show more works
View as search
Works count:
5
Citation count:
30
H-index:
2
I10-index:
1
Year
Topic
Type